Lately, the metabolic regulating role of TGF-β in inducing CAF and endothelial cell generation in cancer was revealed, indicating a novel role of TGF-β signaling in reprogramming the metabolic landscape of the tumor environment. The gene discussed is TGFB1; the disease is neoplasm.